InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Scanlan Sean F., Vice-Président Senior. Insider active across 1 company, notably Treace Medical Concepts, INC.. In total, 28 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €12k. Activity tracked since 10 November 2021. The latest transaction was filed on 9 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Scanlan Sean F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
9,814 shares0Common StockSEC:0001193125-26-347275:0
401 shares0Common StockSEC:0001193125-26-102763:0
16,875 shares@ US$1.056.5% of flowCommon StockSEC:0001193125-26-047313:0
53,500 shares@ US$0.7214.3% of flowCommon StockSEC:0001193125-26-021450:0
208 shares0Common StockSEC:0001193125-25-253801:0
9,814 shares0Common StockSEC:0000950170-25-107555:0
33,437 shares@ US$0.717811.3% of flowCommon StockSEC:0000950170-25-097601:0
50,000 shares@ US$1.0521.2% of flowCommon StockSEC:0000950170-25-042291:0
401 shares0Common StockSEC:0000950170-25-037572:0
140,625 shares0Common StockSEC:0000950170-25-008973:0
4,821 shares0Common StockSEC:0000950170-25-005580:0
33,750 shares@ US$0.09721.3% of flowCommon StockSEC:0000950170-24-106856:0
120,900 shares0Common StockSEC:0000950170-24-095009:0
389 shares0Common StockSEC:0000950170-24-030429:0
65,025 shares0Common StockSEC:0001209191-24-001589:0
211 shares0Common StockSEC:0001209191-23-054433:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-030857:0
505 shares@ US$24.415.1% of flowCommon StockSEC:0001209191-23-018042:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-010955:0
25,000 shares@ US$0.101.0% of flowCommon StockSEC:0001209191-23-003385:0
25,000 shares@ US$0.101.1% of flowCommon StockSEC:0001209191-22-057418:0
3,400 shares0Common StockSEC:0001209191-22-054666:0
6,575 shares0Common StockSEC:0001567619-22-006733:0
25,000 shares@ US$1.0510.2% of flowCommon StockSEC:0001567619-22-006400:0
21,127 shares@ US$1.058.4% of flowCommon StockSEC:0001567619-22-003261:0
25 of 28 declarations
About Scanlan Sean F.
Scanlan Sean F. is Senior Vice-President and Chief Innovation Officer at Treace Medical Concepts, INC. (XNAS). He has 27 filings in total, and across the recent filings available, the reported sell volume is EUR 11685, with no buys, from 2021-11-12 to 2026-03-11, with option exercise as the transaction nature.
